Dfb Oncology Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DFB ONCOLOGY LTD, and what generic and branded alternatives to DFB ONCOLOGY LTD drugs are available?
DFB ONCOLOGY LTD has one approved drug.
Drugs and US Patents for Dfb Oncology Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dfb Oncology Ltd | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 206177-002 | Jan 20, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dfb Oncology Ltd | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 206177-003 | Jan 20, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dfb Oncology Ltd | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 206177-001 | Jan 20, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.